Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Conditions
Interventions
Ticagrelor
Clopidogrel
Locations
776
United States
Research Site
Alexander City, Alabama, United States
Research Site
Auburn, Alabama, United States
Research Site
Birmingham, Alabama, United States
Research Site
Birmingham, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Mobile, Alabama, United States
Start Date
December 4, 2012
Primary Completion Date
September 26, 2016
Completion Date
September 26, 2016
Last Updated
October 30, 2017
NCT05624125
NCT07283289
NCT06212271
NCT06003855
NCT05628948
NCT04794530
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions